Anne Mary Dickinson

Anne Mary Dickinson

Auto-generated profile, based on publicly available information

Anne Mary Dickinson

Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
MRMonica Reis
Monica Reis
EMEmily Mavin
Emily Mavin
LNLindsay Nicholson
Lindsay Nicholson
KGKile Green
Kile Green
ADAnne M. Dickinson
Anne M. Dickinson
XWXiao-Nong Wang
Xiao-Nong Wang
Mesenchymal stromal cells (MSCs) are potent regulators of immune responses largely through paracrine signaling. MSC secreted extracellular vesicles (MSC-EVs) are increasingly recognized as the key paracrine factors responsible for the biological and therapeutic function of MSCs. We report the first comprehensive study demonstrating the immunomodulatory effect of MSC-EVs on dendritic cell (DC) maturation and function. MSC-EVs were isolated from MSC conditioned media using differential ultracentrifugation. Human monocyte-derived DCs were generated in the absence or presence of MSC-EVs (20 ug/ml) then subjected to phenotypic and functional analysis in vitro. MSC-EV treatment impaired antigen uptake by immature DCs and halted DC maturation resulting in reduced expression of the maturation and activation markers CD83, CD38, and CD80, decreased secretion of pro-inflammatory cytokines IL-6 and IL-12p70 and increased production of anti-inflammatory cytokine TGF-β. MSC-EV treated DCs also demonstrated a diminished CCR 7 expression after LPS stimulation, coupled with a significantly reduced ability to migrate toward the CCR7-ligand CCL21, although they were still able to stimulate allogeneic T cell proliferation in vitro. Through microRNA profiling we have identified 49 microRNAs, which were significantly enriched in MSC-EVs compared to their parent MSCs. MicroRNAs with known effect on DC maturation and functions, including miR-21-5p, miR-142-3p, miR-223-3p, and miR-126-3p, were detected within the top 10 most enriched miRNAs in MSC-EVs, with MiR-21-5p as the third highest expressed miRNA in MSC-EVs. In silico analysis revealed that miR-21-5p targets the CCR7 gene for degradation. To verify these observations, DCs were transfected with miR-21-5p mimics and analyzed for their ability to migrate toward the CCR7-ligand CCL21 in vitro. MiR-21-5p mimic transfected DCs showed a clear trend of reduced CCR7 expression and a significantly decreased migratory ability toward the CCL21. Our findings suggest that MSC-EVs are able to recapitulate MSC mediated DC modulation and MSC-EV enclosed microRNAs may represent a novel mechanism through which MSCs modulate DC functions. As MSCs are currently used in clinical trials to treat numerous diseases associated with immune dysregulation, such as graft-versus-host disease and inflammatory bowel disease, our data provide novel evidence to inform potential future application of MSC-EVs as a cell-free therapeutic agent.

7 June 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
ADAnne M. Dickinson
Anne M. Dickinson
JNJean Norden
Jean Norden
SLShuang Li
Shuang Li
Ilona HromadnikovaIlona Hromadnikova
Ilona Hromadnikova
CSChristoph Schmid
Christoph Schmid
HJHans Jochem-Kolb
Hans Jochem-Kolb
The success of haematopoietic stem cell transplantation (HSCT) lies with the ability of the engrafting immune system to remove residual leukaemia cells via a graft versus leukaemia effect, caused either spontaneously post HSCT or via donor lymphocyte infusion. Graft versus leukaemia effects can also be initiated by allogeneic mismatched NK cells, antigen specific T cells and activated dendritic cells of leukemic origin. The history and further application of this graft versus leukaemia effect and the main mechanisms will be discussed and reviewed in this chapter.

1 February 2016 in Journal of Immunological Methods
Verified
Journal Article
Closed access
Rachel E CrosslandRachel E Crossland
Rachel E Crossland
JNJean Norden
Jean Norden
LBLouis A. Bibby
Louis A. Bibby
JDJoanna Davis
Joanna Davis
ADAnne M. Dickinson
Anne M. Dickinson

14 September 2015 in Bone Marrow Transplantation
Verified
Journal Article
Closed access
SAS S Ahmed
S S Ahmed
XWX N Wang
X N Wang
JNJ Norden
J Norden
KPK Pearce
K Pearce
EEE El-Gezawy
E El-Gezawy
ADA M Dickinson
A M Dickinson

12 February 2014 in BMC Medical Imaging
Verified
Journal Article
Open access
PDF file
JHJuliana M Haggerty
Juliana M Haggerty
XWXiao N Wang
Xiao N Wang
ADAnne Dickinson
Anne Dickinson
COChris J O’mAlley
Chris J O’mAlley
EMElaine B Martin
Elaine B Martin
Digital image analysis has the potential to address issues surrounding traditional histological techniques including a lack of objectivity and high variability, through the application of quantitative analysis. A key initial step in image analysis is the identification of regions of interest. A widely applied methodology is that of segmentation. This paper proposes the application of image analysis techniques to segment skin tissue with varying degrees of histopathological damage. The segmentation of human tissue is challenging as a consequence of the complexity of the tissue structures and inconsistencies in tissue preparation, hence there is a need for a new robust method with the capability to handle the additional challenges materialising from histopathological damage.

11 March 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RCRichard J Cuthbert
Richard J Cuthbert
PGPeter V Giannoudis
Peter V Giannoudis
XWXiao N Wang
Xiao N Wang
LNLindsay Nicholson
Lindsay Nicholson
DPDavid Pawson
David Pawson
Elena A JonesElena A Jones
Elena A Jones
Current clinical trials utilize mesenchymal stromal cells (MSCs) expanded in culture, however these interventions carry considerable costs and concerns pertaining to culture-induced losses of potency. This study assessed the feasibility of new clinical-grade technology to obtain uncultured MSC isolates from three human intra-osseous tissue sources based on immunomagnetic selection for CD271-positive cells. MSCs were isolated from bone marrow (BM) aspirates or surgical waste materials; enzymatically digested femoral heads (FHs) and reamer irrigator aspirator (RIA) waste fluids. Flow cytometry for the CD45−/lowCD73+CD271+ phenotype was used to evaluate uncultured MSCs before and after selection, and to measure MSC enrichment in parallel to colony forming-unit fibroblast assay. Trilineage differentiation assays and quantitative polymerase chain-reaction for key transcripts involved in bone regeneration was used to assess the functional utility of isolated cells for bone repair. Uncultured CD45−/lowCD271+ MSCs uniformly expressed CD73, CD90 and CD105 but showed variable expression of MSCA-1 and SUSD2 (BM>RIA>FH). MSCs were enriched over 150-fold from BM aspirates and RIA fluids, whereas the highest MSC purities were obtained from FH digests. Enriched fractions expressed increased levels of BMP-2, COL1A2, VEGFC, SPARC and CXCL12 transcripts (BM>RIA>FH), with the highest up-regulation detected for CXCL12 in BM (>1300-fold). Following culture expansion, CD271-selected MSCS were tri-potential and phenotypically identical to plastic adherence-selected MSCs. A CD271-based GMP-compliant immunomagnetic selection resulted in a substantial increase in MSC purity and elevated expression of transcripts involved in bone formation, vascularisation and chemo-attraction. Although this technology, particularly from RIA fluids, can be immediately applied by orthopaedic surgeons as autologous therapy, further improvements in MSC purities and pre-clinical testing of product safety would be required to develop this process for allogeneic applications.